C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2006
11/16/2006	CA2607874A1 Quinoline derivatives as neurokinin receptor antagonists
11/16/2006	CA2607639A1 Crystal of indole derivative having piperidine ring and process for production thereof
11/16/2006	CA2598365A1 Analogs of 4-hydroxyisoleucine and uses thereof
11/15/2006	EP1721904A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
11/15/2006	EP1721522A2 Substituted phenylketo-enoles as biocides and herbicides
11/15/2006	EP1720868A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
11/15/2006	EP1720863A2 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
11/15/2006	EP1720859A2 Chemokine receptor antagonists
11/15/2006	EP1720857A1 Dihydropyridinone derivatives
11/15/2006	EP1720855A1 Inhibitors of akt activity
11/15/2006	EP1720843A2 Process for the preparation of substituted triazole compounds
11/15/2006	EP1720841A2 Quinazoline derivatives and therapeutic use thereof
11/15/2006	EP1720840A2 Methods to manufacture 1,3-dioxolane nucleosides
11/15/2006	EP1720839A1 Pyridazinones as antagonists of a4 integrins
11/15/2006	EP1720836A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo [d]azepines as 5-ht2c receptor agonists
11/15/2006	EP1720553A1 Pyrimidine compounds as purine receptor antagonist
11/15/2006	EP1720546A1 Novel, sustained-action beta-2-agonists and their use as medicaments
11/15/2006	EP1720542A1 Arylalkylamino-substituted quinazoline analogues
11/15/2006	EP1438306A4 Derivatives of uk-2a
11/15/2006	EP1401434B1 Modulators of peroxisome proliferator activated receptors (ppar)
11/15/2006	EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006	EP0931078B1 Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
11/15/2006	CN1863795A P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
11/15/2006	CN1863780A Protein kinase inhibitors and uses thereof
11/15/2006	CN1863778A Compounds and methods for treating dyslipidemia
11/15/2006	CN1863777A Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
11/15/2006	CN1863770A Cyclic amine BASE-1 inhibitors having a heterocyclic substituent
11/15/2006	CN1863768A 8-aza-11-deoxy prostaglandin analogues
11/15/2006	CN1284793C C-aryl glucoside sglt2 inhibitors
11/15/2006	CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase
11/15/2006	CN1284771C TNF－α生成抑制剂 TNF-α production inhibitor
11/15/2006	CN1284763C Compound for preparing protease inhibitor
11/14/2006	US7135576 Process for preparing glycidylphthalimide
11/14/2006	US7135575 P38 inhibitors and methods of use thereof
11/14/2006	US7135495 Indole derivatives
11/14/2006	US7135493 HDAC inhibitor
11/14/2006	US7135491 5-Aryltetrazole compounds and uses thereof
11/14/2006	US7135486 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
11/14/2006	US7135483 Substituted heterocyclic compounds for treating multidrug resistance
11/14/2006	US7135479 Compounds which are both serotonin reuptake inhibitors and antagonists of the 5HT1A receptor
11/14/2006	US7135473 Cyclic diamine compound with condensed-ring groups
11/14/2006	US7135472 3-Heterocyclic benzylamide derivatives as potassium channel openers
11/14/2006	US7135466 used in the treatment of diseases mediated by the autophosphorylation of a PDGF receptor, specifically, compounds which can inhibit neointima formation hypertrophy.
11/14/2006	CA2342271C Gem substituted hydroxamic acids
11/14/2006	CA2274669C 1,5-benzodiazepine derivatives
11/14/2006	CA2244363C Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
11/14/2006	CA2128955C Tricyclic benzazepine vasopressin antagonists
11/09/2006	WO2006119451A1 Pyrimidines and pyrazines useful as modulators of ion channels
11/09/2006	WO2006119400A2 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-trianzin-6-ones, and their use as fungicides
11/09/2006	WO2006118351A1 Mono-lysine salts of azole compounds
11/09/2006	WO2006118256A1 2-aminoquinazoline derivatives
11/09/2006	WO2006117370A1 4-PHENYL-5-OXO-l,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY
11/09/2006	WO2006117368A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility
11/09/2006	WO2006117183A1 3 -m0n0- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors
11/09/2006	WO2005120503A3 N-aryl piperidine compounds for inhibiting hiv infection
11/09/2006	WO2005079802A8 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
11/09/2006	WO2005013988A8 2-`4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity
11/09/2006	US20060252940 Crystalline 1-[2-(2,4-difluorophenyl)-oxiranyl methyl]-1h-1,2,4-triazole
11/09/2006	US20060252813 Apparatus for curing a composite laminate
11/09/2006	US20060252810 e.g. 5-(4-Fluorophenyl)-4-(4-pyridinyl)imidazole-2-thio-3-propyl-N-phthalimide; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
11/09/2006	US20060252795 Chemokine receptor binding heterocyclic compounds
11/09/2006	US20060252793 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide
11/09/2006	US20060252778 Compounds for the treatment of inflammatory disorders
11/09/2006	US20060252769 Obesity, type 2 diabetes, sleep disorders, ischaemic or haemorrhagic strokes, antiemetic; toxicity; side effect reduction; 2-((benzofuran-4-yl)carbonylaminomethyl)-1-((4-(5-(4-fluorophenyl)-2-methyl)thiazolyl)carbonyl)-4-methylpiperazine
11/09/2006	US20060252768 2,3,6-Trisubstituted-4-pyrimidone derivatives
11/09/2006	US20060252767 Piperazine derivatives and their use as therapeutic agents
11/09/2006	US20060252766 Methods using a combination of 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/09/2006	US20060252764 HIV inhibiting pyrimidines derivatives
11/09/2006	US20060252752 Octahydrocyclopenta[b]pyrrole-sulfonamide-2-carboxylic acid derivatives; reduced side effects
11/09/2006	US20060252751 specific compound N-(2-{[(3R)-1-(4-hydroxy-4-pyrimidin-4-ylcyclohexyl)pyrrolidin-3-yl]amino}-2-oxoethyl)-3-(trifluoromethyl)benzamide; multiple sclerosis; CCR2 and/or CCR5 antagonists
11/09/2006	US20060252747 Substitituted 1-piperidin-3-yl-piperidin 4-yl-piperazine derivatives and their use as neurokinin auantagonists
11/09/2006	CA2606683A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
11/09/2006	CA2606682A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
11/09/2006	CA2606538A1 3 -m0n0- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors
11/08/2006	EP1719770A2 Quinoline derivatives as antibacterials
11/08/2006	EP1719761A1 Novel heterocyclic compound
11/08/2006	EP1718640A1 Novel crystalline forms of conazoles and methods of making and using the same
11/08/2006	EP1718639A2 Caspase inhibitors and uses thereof
11/08/2006	EP1718635A1 Piperidinyl targeting compounds that selectively bind integrins
11/08/2006	EP1718632A1 Pyrimidine derivatives as orexin receptor antagonists
11/08/2006	EP1718625A1 Compounds
11/08/2006	EP1718622A2 Electroluminescent device
11/08/2006	EP1718617A2 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
11/08/2006	EP1718615A1 Novel quinoline-carbaxamides as jack3 kinase modulators
11/08/2006	EP1718613A1 Pyridine derivatives and their use as cb2 receptor modulators
11/08/2006	EP1718608A1 Viral polymerase inhibitors
11/08/2006	EP1718604A1 Immunosuppressant compounds and compositions
11/08/2006	EP1539742B1 Indole derivatives useful as histamine h3 antagonists
11/08/2006	CN1860111A Compounds and compositions as protein kinase inhibitors
11/08/2006	CN1859912A Inhibitors of Akt activity
11/08/2006	CN1859904A Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
11/08/2006	CN1283626C Substituted benzene derivatives or salts thereof
11/07/2006	US7132551 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimers, Parkinsons, Lesche-Nyhane, Wilsons, and Tourettes syndrome
11/07/2006	US7132449 useful for the therapeutic treatment of Trypanosoma cruzi infection
11/07/2006	US7132445 Antiinflammatory agents; anticancer agents; analgesics; antiarthritic agents; inflammatory bowel disorders; respiratory system disorders
11/07/2006	US7132440 such as 2-[4-(2-Phenyl-[1,3]dioxolan-2-yl)-phenyl]-1H-benzoimidazole-5-carboxylic acid amide; for treatment of cancer
11/07/2006	US7132438 Benzimidazole derivatives
11/07/2006	US7132434 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders
11/07/2006	US7132425 5-substituted-six-membered heteroaromatic glucokinase activators
11/07/2006	US7132423 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme

1 ... 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 ... 694